Outcome of Board Meeting

Date: September 28, 2026 National Stock Exchange of India Ltd., BSE Limited Exchange Plaza, C-1, Block G, Phiroze Jeejeebhoy Towers Bandra Kurla Complex, Dalal Street Bandra (E), Mumbai – 400 051 Mumbai- 400001 NSE Scrip Symbol: PRASOLCHEM BSE Scrip Code: 544912 Subject: Outcome of Board Meeting held today i.e. Monday, 28th September, 2026 Dear Sir / Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure requirements) Regulations 2015, we wish to inform you that the Board of Directors of the Company at their meeting held today i.e. Monday, 28th September, 2026 at 5:00 P.M. inter-alia, considered following matter: 1. Approved the Unaudited Financial Results along with Limited Review Report of Statutory Auditors for the quarter ended on 30th June, 2026 in accordance with Indian Accounting Standards (IND AS) as per Companies (Indian Accounting Standards) Rules, 2015. Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith, the Unaudited Financial Results for the quarter ended 30th June, 2026 along with Limited Review Report of Statutory Auditors of the Company. 2. Noting of retirement of Dr. Chitra Vaidya, Vice-President – R&D, of the Company being Senior Managerial Personnel. The details required in terms of Regulation 30 of the SEBI Listing Regulations read with SEBI Master Circular No HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 dated January 30, 2026, issued in this regard, are given in Annexure – I. The meeting of the Board of Directors concluded at 06:45 P.M. Kindly take on record the above disclosures for your further necessary action and acknowledge the receipt. Thanking you, Yours faithfully, FOR PRASOL CHEMICALS LIMITED KIRAN RAJENDRA AGRAWAL Company Secretary & Compliance Officer Membership No. : A13188 Annexure-I Information pursuant to Regulation 30 of the SEBI Listing Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 Sr. Particulars Details 1. Reason for change viz. appointment, Resignation, removal, Retirement of Ms. Chitra death or otherwise. Vaidya, Vice-President – R&D, Senior Management Personnel. 2. Date of Appointment / reappointment / cessation (as With effect from the close of applicable) & term of appointment / re-appointment. business hours of September 30, 2026. 3. Brief Profile (In case of Appointment) Not Applicable 4. Disclosure of relationship between Directors (In case of Not Applicable Appointment) CNK & Associates LLP Chartered Accountants Independent Auditor’s Limited Review Report on Quarterly Unaudited Financial Results of Prasol Chemicals Limited (the "Company") pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended To the Board of Directors of Prasol Chemicals Limited 1. We have reviewed the accompanying Statement of Unaudited Financial Results of Prasol Chemical Limited (the "Company") for the quarter ended June 30, 2026, (the "Statement") attached herewith, being submitted by the Compzny pursuant to the requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, (as amended), including relevant circulars issued by the SEBI from time to time (the "Listing Regulations"). 2. This Statement, which is the responsibility of the Company's Management and approved by the Company's Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34 "Interim Financial Reporting" (IND AS 34), prescribed under Section 133 of the Companies Act, 2013, as amended, read with relevant rules issued thereunder as amended from time to time and other accounting principles generally accepted in India and in compliance with the presentation and disclosure requirement of Regulation 33 of the Listing Regulations. Our responsibility is to express a conclusion on the Statement based on our review. 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410, “Review of Interim Financial Information Performed by the Independent Auditor of the Entity” issued by the Institute of Chartered Accountants of India (ICAI). This standard requires that we plan and perform the review to obtain limited assurance as to whether the Statement is free of material misstatement. A review of interim financial information consists of making inquiries, primarily of personnel responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. 4. Based on our review conducted and procedures performed as stated in paragraph 3 above and based on the considerations referred to in paragraphs 5 & 6 below, nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in accordance with the applicable Indian Accounting Standards and other recognized accounting principles generally accepted in India, has not disclosed the information required to be disclosed in accordance with the requirement of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 (as amended), including the manner in which it is to be disclosed, or that it contains any material misstatement. Mistry Bhavan, 3rd Floor, Dinshaw Vachha Road, Churchgate, Mumbai 400 020. Tel: +91 22 6623 0600 501-502, Narain Chambers, M.G. Road, Vile Parle (E), Mumbai 400 057. Tel: +91 22 6250 7600 Website: www.cnkindia.com MUMBAI | CHENNAI | VADODARA| AHMEDABAD | GIFT CITY | GURUGRAM| BENGALURU | DELHI | PUNE | KOLKATA | DUBAI | ABU DHABI | SHARJAI 5. Attention is drawn to the fact that the financial results for the quarter ended June 30, 2025 as reported in the Statement were audited by us for the purpose of inclusion in Offer Documents in relation to Initial Public Offer (IPO). 6. Attention is drawn to the fact that the accompanying Statement includes the results for the quarter ended March 31, 2026 which were approved by the Board of Directors at their meeting held on September 28, 2026 and have neither been audited nor been reviewed. 7. Emphasis of Matter As stated in note no. 6 of the Statement, the Company has incurred an expenditure of Rs. 31.86 million (including Rs. 2.64 million incurred during the quatter under review) in relation to the IPO. The same is included under Other Current Assets and is proposed to be charged to Securities Premium account once the process of IPO is completed. Our report is not modified in respect of the above matter. For CN K & Associates LLP Chartered Accountants Firm Registration No. 101961WW/' Diwakar Sapre Partner Membership No. 040740 UDIN: 26040740QXMVMA8544 Place: Mumbai Date: September 28, 2026 TED 2 MICALS 1 1992P1 e A e P R 2R Statement of Unaudited Financial Results for the Quarter Ended June 30, 2026 (Rs. In Millions) SrNo Particulacs For the quarter ended Year ended Jun 30,2026 | Mar31,2026 | Jun30,2025 | Mar 31,2026 Reviewed | (Refer Note | (Refer Note Audited No) No#) Income 1 [Siles 432090 34047 3,188.10 12,287.94 2 |Other operaiing income 1556 865 750 3199 3 [Revenue from operations (1+2) 433646 334012 3,195.60 1232593 4 |Otherincome 1711 2n 876 5252 5 [Toulincome G+4) 4,353.57 337183 3.204.36 12,378.95 Expenses @ |Costs of matesials consumed 220541 184831 1,705.29 688467 @ [Purchases of stockin-trade 871.63 982 46821 1,750.88 () |Changes in inventories of finished goods, work-in-progress and stock-n-zade 09199) 2060 63.68 96.47) @ ployee benefits expense 13292 16154 106.26 503,66 (@ |Finance costs 1821 1571 2675 771 (0 [Depreciadion and smorisation expense G611 @9 018 24 [Showing first 8,000 characters — download PDF for full document]